Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

K Jamerson, MA Weber, GL Bakris… - … England Journal of …, 2008 - Mass Medical Soc
Background The optimal combination drug therapy for hypertension is not established,
although current US guidelines recommend inclusion of a diuretic. We hypothesized that …

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified …

GL Bakris, PA Sarafidis, MR Weir, B Dahlöf, B Pitt… - The Lancet, 2010 - thelancet.com
Summary Background The Avoiding Cardiovascular Events through Combination Therapy
in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial …

Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a …

MA Weber, GL Bakris, B Dahlöf, B Pitt… - Blood …, 2007 - Taylor & Francis
ACCOMPLISH is the first trial designed to compare the effects on major fatal and non‐fatal
cardiovascular endpoints of two forms of antihypertensive combination therapy: benazepril …

Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first …

KA Jamerson, GL Bakris, CC Wun… - American journal of …, 2004 - academic.oup.com
Reducing blood pressure (BP) to target levels is a major priority in preventing clinical events
in hypertension. Typically this requires more than one drug, and recent guidelines on …

Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial

M Matsuzaki, T Ogihara, S Umemoto… - Journal of …, 2011 - journals.lww.com
Objectives Current guidelines recommend the use of multiple medications for hypertension.
The present study was aimed at determining which combination was optimal to prevent …

Cardiovascular events during differing hypertension therapies in patients with diabetes

MA Weber, GL Bakris, K Jamerson, M Weir… - Journal of the American …, 2010 - jacc.org
Objectives: The aim of this study was to determine which combination therapy in patients
with hypertension and diabetes most effectively decreases cardiovascular events …

Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel …

KA Jamerson, O Nwose, L Jean-Louis… - American journal of …, 2004 - academic.oup.com
Abstract Background: The Seventh Report of the Joint National Committee (JNC 7) on
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommends …

Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or …

FH Messerli, S Oparil, Z Feng - The American journal of cardiology, 2000 - Elsevier
The present 2 multicenter studies were designed to evaluate whether patients with essential
hypertension derived equal benefits from use of combination therapy with a calcium …

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive …

T Antihypertensive… - Jama, 2002 - pubmed.ncbi.nlm.nih.gov
Context Antihypertensive therapy is well established to reduce hypertension-related
morbidity and mortality, but the optimal first-step therapy is unknown. Objective To determine …

Comparison of cardiovascular events among users of different classes of antihypertension medications: a systematic review and network meta-analysis

J Wei, KI Galaviz, AJ Kowalski, MJ Magee… - JAMA network …, 2020 - jamanetwork.com
Importance Antihypertension medications have been associated with prevention of
cardiovascular events, although less is known about the comparative effectiveness of …